SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — FibroGen Inc. (FGEN) on Monday reported a loss of $56.2 million in its fourth quarter.
The San Francisco-based company said it had a loss of 57 cents per share.
The biotech drug developer posted revenue of $27.1 million in the period.
For the year, the company reported a loss of $284.2 million, or $2.92 per share. Revenue was reported as $147.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FGEN at https://www.zacks.com/ap/FGEN
Advertisement